nach oben

Erschienen in:

01.12.2024 | Original Paper

Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI

verfasst von: Duojin Xia, Haiyang Zhang, Hui Wang, Mengda Jiang, Yan Tang, Yinwei Li, Jing Sun, Xuefei Song, Huifang Zhou

Erschienen in: International Ophthalmology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to explore the diagnostic value of whole-orbit-based multiparametric assessment on Dixon MRI for the evaluation of the thyroid eye disease (TED) activity.

Methods

The retrospective study enrolled patients diagnosed as TED and obtained their axial and coronal Dixon MRI scans. Multiparameters were assessed, including water fraction (WF), fat fraction (FF) of extraocular muscles (EOMs), orbital fat (OF), and lacrimal gland (LG). The thickness of OF and herniation of LG were also measured. Univariable and multivariable logistic regression was applied to construct prediction models based on single or multiple structures. Receiver operating characteristic (ROC) curve analysis was also implemented.

Results

Univariable logistic analysis revealed significant differences in water fraction (WF) of the superior rectus (P = 0.018), fat fraction (FF) of the medial rectus (P = 0.029), WF of OF (P = 0.004), and herniation of LG (P = 0.012) between the active and inactive TED phases. Multivariable logistic analysis and corresponding receiver operating characteristic curve (ROC) analysis of each structure attained the area under the curve (AUC) values of 0.774, 0.771, and 0.729 for EOMs, OF, and LG, respectively, while the combination of the four imaging parameters generated a final AUC of 0.909.

Conclusions

Dixon MRI may be used for fine multiparametric assessment of multiple orbital structures. The whole-orbit-based model improves the diagnostic performance of TED activity evaluation.

Bahn RS (2010) Graves’ ophthalmopathy. N Engl J Med 362(8):726–738. https://doi.org/10.1056/NEJMra0905750CrossRefPubMedPubMedCentral

Douglas RS et al (2020) Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382(4):341–352. https://doi.org/10.1056/NEJMoa1910434CrossRefPubMed

Bartalena L, Tanda ML (2022) Current concepts regarding Graves’ orbitopathy. J Intern Med 292(5):692–716. https://doi.org/10.1111/joim.13524CrossRefPubMedPubMedCentral

Bartalena L et al (2021) The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 185(4):G43–G67. https://doi.org/10.1530/EJE-21-0479CrossRefPubMed

Li Y et al (2024) Use of extreme gradient boosting, light gradient boosting machine, and deep neural networks to evaluate the activity stage of extraocular muscles in thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 262(1):203–210. https://doi.org/10.1007/s00417-023-06256-1CrossRefPubMed

Mawn LA et al (2018) Soft tissue metrics in thyroid eye disease: an international thyroid eye disease society reliability study. Ophthalmic Plast Reconstr Surg 34(6):544–546. https://doi.org/10.1097/IOP.0000000000001080CrossRefPubMed

Bartalena L et al (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158(3):273–285. https://doi.org/10.1530/EJE-07-0666CrossRefPubMed

Tachibana S et al (2010) Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves’ ophthalmopathy. Endocr J 57(10):853–861. https://doi.org/10.1507/endocrj.k10e-156CrossRefPubMed

Das T et al (2019) T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study. Eye (Lond) 33(2):235–243. https://doi.org/10.1038/s41433-018-0304-zCrossRef

10.

Lecler A (2021) Expanding diagnostic tools for dysthyroid optic neuropathy: how quantitative MRI can be used to visualize and measure orbital inflammation. Eur Radiol 31(10):7417–7418. https://doi.org/10.1007/s00330-021-08208-xCrossRefPubMed

11.

Zhang H et al (2023) Predictive markers for anti-inflammatory treatment response in thyroid eye disease. Front Endocrinol (Lausanne) 14:1292519. https://doi.org/10.3389/fendo.2023.1292519CrossRefPubMed

12.

Liu X et al (2021) Application of magnetic resonance imaging in the evaluation of disease activity in Graves’ ophthalmopathy. Endocr Pract 27(3):198–205. https://doi.org/10.1016/j.eprac.2020.09.008CrossRefPubMed

13.

Ge Q et al (2021) Quantitative evaluation of activity of thyroid-associated ophthalmopathy using short-tau inversion recovery (STIR) sequence. BMC Endocr Disord 21(1):226. https://doi.org/10.1186/s12902-021-00895-3CrossRefPubMedPubMedCentral

14.

Lingam RK, Mundada P, Lee V (2018) Novel use of non-echo-planar diffusion weighted MRI in monitoring disease activity and treatment response in active Grave’s orbitopathy: an initial observational cohort study. Orbit 37(5):325–330. https://doi.org/10.1080/01676830.2017.1423343CrossRefPubMed

15.

Higashiyama T, Iwasa M, Ohji M (2017) Quantitative analysis of inflammation in orbital fat of thyroid-associated ophthalmopathy using MRI signal intensity. Sci Rep 7(1):16874. https://doi.org/10.1038/s41598-017-17257-6CrossRefPubMedPubMedCentral

16.

Ollitrault A et al (2021) Dixon-T2WI magnetic resonance imaging at 3 tesla outperforms conventional imaging for thyroid eye disease. Eur Radiol 31(7):5198–5205. https://doi.org/10.1007/s00330-020-07540-yCrossRefPubMed

17.

Wong NTY et al (2023) Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis. BMC Ophthalmol 23(1):347. https://doi.org/10.1186/s12886-023-03008-xCrossRefPubMedPubMedCentral

18.

Zhang H et al (2023) Application of quantitative MRI in thyroid eye disease: imaging techniques and clinical practices. J Magn Reson Imaging. https://doi.org/10.1002/jmri.29114CrossRefPubMedPubMedCentral

19.

Hu H et al (2020) Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues. Endocrine 70(2):372–379. https://doi.org/10.1007/s12020-020-02367-5CrossRefPubMed

20.

Cheng J et al (2023) Evaluation of activity of Graves’ orbitopathy with multiparameter orbital magnetic resonance imaging (MRI). Quant Imaging Med Surg 13(5):3040–3049. https://doi.org/10.21037/qims-22-814CrossRefPubMedPubMedCentral

21.

Zhang H et al (2024) Whole-orbit radiomics: machine learning-based multi- and fused- region radiomics signatures for intravenous glucocorticoid response prediction in thyroid eye disease. J Transl Med 22(1):56. https://doi.org/10.1186/s12967-023-04792-2CrossRefPubMedPubMedCentral

22.

Bartalena L (2013) Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol 9(12):724–734. https://doi.org/10.1038/nrendo.2013.193CrossRefPubMed

23.

Song C et al (2023) Extraocular muscle volume index at the orbital apex with optic neuritis: a combined parameter for diagnosis of dysthyroid optic neuropathy. Eur Radiol 33(12):9203–9212. https://doi.org/10.1007/s00330-023-09848-xCrossRefPubMed

24.

Xu L et al (2017) Thickness of extraocular muscle and orbital fat in MRI predicts response to glucocorticoid therapy in Graves’ ophthalmopathy. Int J Endocrinol 2017:3196059. https://doi.org/10.1155/2017/3196059CrossRefPubMedPubMedCentral

25.

Gagliardo C et al (2020) Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity. Eur Radiol 30(4):2138–2141. https://doi.org/10.1007/s00330-019-06570-5CrossRefPubMed

26.

Wu D et al (2021) Utility of multi-parametric quantitative magnetic resonance imaging of the lacrimal gland for diagnosing and staging Graves’ ophthalmopathy. Eur J Radiol 141:109815. https://doi.org/10.1016/j.ejrad.2021.109815CrossRefPubMed

27.

Chen L et al (2021) Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance. Br J Radiol 94(1118):20200884. https://doi.org/10.1259/bjr.20200884CrossRefPubMed

28.

Armstrong RA (2013) Statistical guidelines for the analysis of data obtained from one or both eyes. Ophthalmic Physiol Opt 33(1):7–14. https://doi.org/10.1111/opo.12009CrossRefPubMed

29.

Ma Z et al (2019) Improvement of the MRI and clinical features of Asian Graves’ ophthalmopathy by radiation therapy with steroids. Jpn J Radiol 37(8):612–618. https://doi.org/10.1007/s11604-019-00846-yCrossRefPubMed

30.

Das T et al (2019) T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study. Eye 33(2):235–243. https://doi.org/10.1038/s41433-018-0304-zCrossRefPubMed

31.

Chaobin ZYHXZZLCZ (2021) Clinical significance of Dixon quantificatioin in evaluation of thyroid⁃related ophthalmopathy. Chin J Biomed Eng. https://doi.org/10.3760/cma.j.cn115668⁃20210601⁃00112CrossRef

32.

Lee BW et al (2018) Transcriptome analysis of orbital adipose tissue in active thyroid eye disease using next generation RNA sequencing technology. Open Ophthalmol J 12:41–52. https://doi.org/10.2174/1874364101812010041CrossRefPubMedPubMedCentral

33.

Garau LM et al (2018) Extraocular muscle sampled volume in Graves’ orbitopathy using 3-T fast spin-echo MRI with iterative decomposition of water and fat sequences. Acta Radiol Open 7(6):2058460118780892. https://doi.org/10.1177/2058460118780892CrossRefPubMedPubMedCentral

34.

Nagy EV et al (2000) Graves’ ophthalmopathy: eye muscle involvement in patients with diplopia. Eur J Endocrinol 142(6):591–597. https://doi.org/10.1530/eje.0.1420591CrossRefPubMed

35.

Imbrasienė D, Jankauskienė J, Stanislovaitienė D (2010) Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves’ ophthalmopathy. Medicina (Kaunas) 46(7):472–476CrossRefPubMed

36.

Keene KR et al (2021) The feasibility of quantitative MRI of extra-ocular muscles in myasthenia gravis and Graves’ orbitopathy. NMR Biomed 34(1):4407. https://doi.org/10.1002/nbm.4407CrossRef

37.

Kaichi Y et al (2019) Thyroid-associated orbitopathy: quantitative evaluation of the orbital fat volume and edema using IDEAL-FSE. Eur J Radiol Open 6:182–186. https://doi.org/10.1016/j.ejro.2019.05.003CrossRefPubMedPubMedCentral

38.

Nedeljkovic Beleslin B et al (2014) Efficacy and safety of combined parenteral and oral steroid therapy in Graves’ orbitopathy. Hormones (Athens) 13(2):222–228. https://doi.org/10.1007/BF03401336CrossRefPubMed

39.

van Vucht N et al (2019) The Dixon technique for MRI of the bone marrow. Skeletal Radiol 48(12):1861–1874. https://doi.org/10.1007/s00256-019-03271-4CrossRefPubMed

40.

Ma J (2004) Breath-hold water and fat imaging using a dual-echo two-point Dixon technique with an efficient and robust phase-correction algorithm. Magn Reson Med 52(2):415–419. https://doi.org/10.1002/mrm.20146CrossRefPubMed

41.

Reeder SB et al (2004) Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn Reson Med 51(1):35–45. https://doi.org/10.1002/mrm.10675CrossRefPubMed

42.

Huang K et al (2023) Image quality and evaluation ability of magnetic resonance imaging techniques for thyroid-associated ophthalmopathy: Dixon fat-suppression technique vs. spectral attenuated inversion recovery. Front Med (Lausanne) 10:1154828. https://doi.org/10.3389/fmed.2023.1154828CrossRefPubMed

43.

Gaddikeri S et al (2018) Optimal fat suppression in head and neck mri: comparison of multipoint Dixon with 2 different fat-suppression techniques, spectral presaturation and inversion recovery, and STIR. AJNR Am J Neuroradiol 39(2):362–368. https://doi.org/10.3174/ajnr.A5483CrossRefPubMedPubMedCentral

44.

Kijowski R et al (2009) Improved fat suppression using multipeak reconstruction for IDEAL chemical shift fat-water separation: application with fast spin echo imaging. J Magn Reson Imaging 29(2):436–442. https://doi.org/10.1002/jmri.21664CrossRefPubMedPubMedCentral

45.

Dixon WT (1984) Simple proton spectroscopic imaging. Radiology 153(1):189–194. https://doi.org/10.1148/radiology.153.1.6089263CrossRefPubMed

46.

Ma J (2008) Dixon techniques for water and fat imaging. J Magn Reson Imaging 28(3):543–558. https://doi.org/10.1002/jmri.21492CrossRefPubMed

Titel: Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI
verfasst von: Duojin Xia
Haiyang Zhang
Hui Wang
Mengda Jiang
Yan Tang
Yinwei Li
Jing Sun
Xuefei Song
Huifang Zhou
Publikationsdatum: 01.12.2024
Verlag: Springer Netherlands
Erschienen in: International Ophthalmology / Ausgabe 1/2024
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-024-03138-1

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Efficacy of hydroxypropyl-guar drops in improving tear film index and ocular surface dynamics using two treatment methods under a controlled desiccating environment

Higher order aberrations in keratoconus‏

Comparison of preoperative prophylaxis with povidone–iodine (5%) and moxifloxacin (0.5%) versus povidone–iodine (5%) alone: a prospective study from India

The practical and educational value of scleral buckling with chandelier illumination

Pattern electroretinography response in amblyopic adults

Complications after CyPass® Micro-Stent explantation: a case series

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde